Muta Abiff, MD, PhD
RESIDENT
Surgery
School of Medicine

Publications (3)

Top publication keywords:
Ion ChannelsAntineoplastic AgentsLung NeoplasmsCryosurgeryAnimalsCross-PrimingMiceNeoplasmsDendritic CellsCD11b AntigenT-Lymphocytes, RegulatoryCD8-Positive T-LymphocytesTumor MicroenvironmentAdaptive ImmunityRhabdomyosarcoma

• Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells.
  Journal for immunotherapy of cancer 2025 Bonner M, Askew D, Sathish Kumar V, Tomchuck SL, Eid S, Abiff M, Myers JT, Nguyen P, Garyu JWA, Miller TE, Huang AY
• Piezo1 facilitates optimal T cell activation during tumor challenge.
  Oncoimmunology 2023 Abiff M, Alshebremi M, Bonner M, Myers JT, Kim BG, Tomchuck SL, Santin A, Kingsley D, Choi SH, Huang AY
• Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation.
  Journal for immunotherapy of cancer 2023 Alshebremi M, Tomchuck SL, Myers JT, Kingsley DT, Eid S, Abiff M, Bonner M, Saab ST, Choi SH, Huang AY